Private Label Supplements
L-carnitine impacts glutamatergic neurotransmission [66], while ALA, through its conversion to omega-3 fatty acids, modulates both serotonergic and dopaminergic pathways [67, 68], a key phenomenon in migraine pathogenesis [4]
GLP-1 products, for the most part, are just repackaging common supplement ingredients
IGF-I deficiency is associated with growth hormone insensitivity syndrome (GHIS) also called Laron syndrome, liver cirrhosis, age-related cardiovascular and neurological diseases, and intrauterine growth restriction
Its also important to keep in mind that fibroids thrive around estrogen
In 2025, semaglutide received approval from the U.S